Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis

References

• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298-307; PMID:21593862; http://dx.doi.org/10.1038/nature10144
   PubMed Web of Science ®Google Scholar
• Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011; 17:1359-70; PMID:22064426; http://dx.doi.org/10.1038/nm.2537
   PubMed Web of Science ®Google Scholar
• Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146:873-87; PMID:21925313; http://dx.doi.org/10.1016/j.cell.2011.08.039
   PubMed Web of Science ®Google Scholar
• Watari K, Nakaya M, Kurose H. Multiple functions of G protein-coupled receptor kinases. J Mol Signal 2014; 9:1; PMID:24597858; http://dx.doi.org/10.1186/1750-2187-9-1
   PubMedGoogle Scholar
• Penela P, Murga C, Ribas C, Lafarga V, Mayor F, Jr. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 2010; 160:821-32; PMID:20590581; http://dx.doi.org/10.1111/j.1476-5381.2010.00727.x
   PubMed Web of Science ®Google Scholar
• Rivas V, Carmona R, Munoz-Chapuli R, Mendiola M, Nogues L, Reglero C, Miguel-Martin M, Garcia-Escudero R, Dorn GW, 2nd, Hardisson D, et al. Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J Clin Invest 2013; 123:4714-30; PMID:24135140; http://dx.doi.org/10.1172/JCI67333
   PubMed Web of Science ®Google Scholar
• van Meeteren LA, Goumans MJ, ten Dijke P. TGF-beta receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy. Curr Pharm Biotechnol 2011; 12:2108-20; PMID:21619534; http://dx.doi.org/10.2174/138920111798808338
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003; 12:817-28; PMID:14580334; http://dx.doi.org/10.1016/S1097-2765(03)00386-1
   PubMed Web of Science ®Google Scholar
• Orlova VV, Liu Z, Goumans MJ, ten Dijke P. Controlling angiogenesis by two unique TGF-beta type I receptor signaling pathways. Histol Histopathol 2011; 26:1219-30; PMID:21751154
   PubMed Web of Science ®Google Scholar
• Tung JJ, Tattersall IW, Kitajewski J. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2012; 2:a006601; PMID:22355796; http://dx.doi.org/10.1101/cshperspect.a006601
   PubMed Web of Science ®Google Scholar
• Bridges E, Oon CE, Harris A. Notch regulation of tumor angiogenesis. Future Oncol 2011; 7:569-88; PMID:21463145; http://dx.doi.org/10.2217/fon.11.20
   PubMed Web of Science ®Google Scholar
• Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell 2009; 16:196-208; PMID:19217422; http://dx.doi.org/10.1016/j.devcel.2009.01.015
   PubMed Web of Science ®Google Scholar
• Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008; 456:809-13; PMID:18997771; http://dx.doi.org/10.1038/nature07424
   PubMed Web of Science ®Google Scholar
• Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Brakenhielm E, Cao Y. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 2007; 117:2766-77; PMID:17909625; http://dx.doi.org/10.1172/JCI32479
   PubMed Web of Science ®Google Scholar
• Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res 2010; 180:103-14; PMID:20033380; http://dx.doi.org/10.1007/978-3-540-78281-0_7
   PubMedGoogle Scholar
• Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314:15-23; PMID:12883993; http://dx.doi.org/10.1007/s00441-003-0745-x
   PubMed Web of Science ®Google Scholar
• Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003; 17:1835-40; PMID:12897053; http://dx.doi.org/10.1101/gad.266803
   PubMed Web of Science ®Google Scholar
• Taylor LM, Khachigian LM. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J Biol Chem 2000; 275:16709-16; PMID:10828062; http://dx.doi.org/10.1074/jbc.275.22.16709
   PubMed Web of Science ®Google Scholar
• Ho J, Cocolakis E, Dumas VM, Posner BI, Laporte SA, Lebrun JJ. The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. EMBO J 2005;24:3247-3258; PMID:16121194; http://dx.doi.org/10.1038/sj.emboj.7600794
   PubMed Web of Science ®Google Scholar
• David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007; 109:1953-61; PMID:17068149; http://dx.doi.org/10.1182/blood-2006-07-034124
   PubMed Web of Science ®Google Scholar
• David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ, Bailly S. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 2008; 102:914-22; PMID:18309101; http://dx.doi.org/10.1161/CIRCRESAHA.107.165530
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003; 12:817-828; PMID:14580334; http://dx.doi.org/10.1016/S1097-2765(03)00386-1
   PubMed Web of Science ®Google Scholar
• Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 2000; 26:328-31; PMID:11062473; http://dx.doi.org/10.1038/81634
   PubMed Web of Science ®Google Scholar
• Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 2000; 97:2626-31; PMID:10716993; http://dx.doi.org/10.1073/pnas.97.6.2626
   PubMed Web of Science ®Google Scholar
• Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 2008; 111:633-42; PMID:17911384; http://dx.doi.org/10.1182/blood-2007-08-107359
   PubMed Web of Science ®Google Scholar
• Larrivee B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 2012; 22:489-500; PMID:22421041; http://dx.doi.org/10.1016/j.devcel.2012.02.005
   PubMed Web of Science ®Google Scholar
• Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006; 444:1032-7; PMID:17183313; http://dx.doi.org/10.1038/nature05355
   PubMed Web of Science ®Google Scholar
• Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 2007; 120:964-72; PMID:17311849; http://dx.doi.org/10.1242/jcs.002949
   PubMed Web of Science ®Google Scholar
• Mallet C, Vittet D, Feige JJ, Bailly S. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 2006; 24:2420-7; PMID:17071858; http://dx.doi.org/10.1634/stemcells.2005-0494
   PubMed Web of Science ®Google Scholar
• Hall K, Ran S. Regulation of tumor angiogenesis by the local environment. Front Biosci (Landmark Ed) 2010; 15:195-212; PMID:20036815; http://dx.doi.org/10.2741/3615
   PubMed Web of Science ®Google Scholar
• Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res 2009; 69:3727-30; PMID:19383906; http://dx.doi.org/10.1158/0008-5472.CAN-08-4289
   PubMed Web of Science ®Google Scholar
• De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 2007; 28:519-24; PMID:17981504; http://dx.doi.org/10.1016/j.it.2007.09.004
   PubMed Web of Science ®Google Scholar
• Penela P, Ribas C, Mayor F, Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal 2003; 15:973-81; PMID:14499340; http://dx.doi.org/10.1016/S0898-6568(03)00099-8
   PubMed Web of Science ®Google Scholar
• Penela P, Murga C, Ribas C, Tutor AS, Peregrin S, Mayor F, Jr. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res 2006; 69:46-56; PMID:16288730
   PubMed Web of Science ®Google Scholar
• Ramos-Ruiz R, Penela P, Penn RB, Mayor F, Jr. Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. Circulation 2000; 101:2083-9; PMID:10790351; http://dx.doi.org/10.1161/01.CIR.101.17.2083
   PubMed Web of Science ®Google Scholar
• Karagiannis GS, Pavlou MP, Diamandis EP. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol Oncol 2010; 4:496-510; PMID:20934395; http://dx.doi.org/10.1016/j.molonc.2010.09.001
   PubMed Web of Science ®Google Scholar
• Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic Inflammation and Cytokines in the Tumor Microenvironment. J Immunol Res 2014; 2014:149185; PMID:24901008; http://dx.doi.org/10.1155/2014/149185
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13:759-71; PMID:24154716; http://dx.doi.org/10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Cobelens PM, Kavelaars A, Heijnen CJ, Ribas C, Mayor F, Jr., Penela P. Hydrogen peroxide impairs GRK2 translation via a calpain-dependent and cdk1-mediated pathway. Cell Signal 2007; 19:269-77; PMID:16963227; http://dx.doi.org/10.1016/j.cellsig.2006.06.009
   PubMed Web of Science ®Google Scholar
• Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, et al. Regulation of β-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 2007; 129:511-22; PMID:17482545; http://dx.doi.org/10.1016/j.cell.2007.02.046
   PubMed Web of Science ®Google Scholar
• Lombardi MS, Kavelaars A, Schedlowski M, Bijlsma JW, Okihara KL, Van de Pol M, Ochsmann S, Pawlak C, Schmidt RE, Heijnen CJ. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 1999; 13:715-25; PMID:10094932
   PubMed Web of Science ®Google Scholar
• Lombardi MS, Vroon A, Sodaar P, van Muiswinkel FL, Heijnen CJ, Kavelaars A. Down-regulation of GRK2 after oxygen and glucose deprivation in rat hippocampal slices: role of the PI3-kinase pathway. J Neurochem 2007; 102:731-40; PMID:17437535; http://dx.doi.org/10.1111/j.1471-4159.2007.04576.x
   PubMed Web of Science ®Google Scholar
• Penela P, Elorza A, Sarnago S, Mayor F, Jr. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J 2001; 20:5129-38; PMID:11566877; http://dx.doi.org/10.1093/emboj/20.18.5129
   PubMed Web of Science ®Google Scholar
• Elorza A, Penela P, Sarnago S, Mayor F, Jr. MAPK-dependent degradation of G protein-coupled receptor kinase 2. J Biol Chem 2003; 278:29164-73; PMID:12738776; http://dx.doi.org/10.1074/jbc.M304314200
   PubMed Web of Science ®Google Scholar
• Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006; 6:240-8; PMID:16498446; http://dx.doi.org/10.1038/nrc1820
   PubMed Web of Science ®Google Scholar
• Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12:939-44; PMID:16862152; http://dx.doi.org/10.1038/nm1447
   PubMed Web of Science ®Google Scholar
• Cole SW, Sood AK. Molecular pathways: β-adrenergic signaling in cancer. Clin Cancer Res 2012; 18:1201-6; PMID:22186256; http://dx.doi.org/10.1158/1078-0432.CCR-11-0641
   PubMed Web of Science ®Google Scholar
• Hubens LE, Verloop WL, Joles JA, Blankestijn PJ, Voskuil M. Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation? Curr Hypertens Rep 2013; 15:313-20; PMID:23754326; http://dx.doi.org/10.1007/s11906-013-0367-y
   PubMed Web of Science ®Google Scholar
• Harris DM, Cohn HI, Pesant S, Eckhart AD. GPCR signalling in hypertension: role of GRKs. Clin Sci (Lond) 2008; 115:79-89; PMID:18593382; http://dx.doi.org/10.1042/CS20070442
   PubMed Web of Science ®Google Scholar
• Dorn GW, 2nd. GRK mythology: G-protein receptor kinases in cardiovascular disease. J Mol Med (Berl) 2009; 87:455-63; PMID:19229505; http://dx.doi.org/10.1007/s00109-009-0450-7
   PubMed Web of Science ®Google Scholar
• Rengo G, Lymperopoulos A, Leosco D, Koch WJ. GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol 2011; 50:785-92; PMID:20800067; http://dx.doi.org/10.1016/j.yjmcc.2010.08.014
   PubMed Web of Science ®Google Scholar
• Mialet-Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB. Beta1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9:1300-1305; PMID:14502278; http://dx.doi.org/10.1038/nm930
   PubMed Web of Science ®Google Scholar
• Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005; 97:1182-9; PMID:16239589; http://dx.doi.org/10.1161/01.RES.0000191541.06788.bb
   PubMed Web of Science ®Google Scholar
• Galasso G, De Rosa R, Ciccarelli M, Sorriento D, Del Giudice C, Strisciuglio T, De Biase C, Luciano R, Piccolo R, Pierri A, et al. beta2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. Circ Res 2013; 112:1026-34; PMID:23418295; http://dx.doi.org/10.1161/CIRCRESAHA.111.300152
   PubMed Web of Science ®Google Scholar
• Ji Y, Chen S, Xiao X, Zheng S, Li K. b-blockers: a novel class of antitumor agents. OncoTargets Ther 2012; 5:391-401; PMID:23226026; http://dx.doi.org/10.2147/OTT.S38403
   PubMed Web of Science ®Google Scholar
• Ji Y, Chen S, Li K, Li L, Xu C, Xiang B. Signaling pathways in the development of infantile hemangioma J. Hematol Oncol 2014; 7:13-26; http://dx.doi.org/10.1186/1756-8722-7-13
   Web of Science ®Google Scholar
• Ji Y, Chen S, Li K, Xiao X, Zheng S Xu T. The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Division 2013; 8:1-12; PMID:23286511; http://dx.doi.org/10.1186/1747-1028-8-1
   PubMed Web of Science ®Google Scholar
• Cook J, Hagemann T. Tumour-associated macrophages and cancer. Curr Opin Pharmacol 2013; 13:595-601; PMID:23773801; http://dx.doi.org/10.1016/j.coph.2013.05.017
   PubMed Web of Science ®Google Scholar
• Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 2013; 91:411-29; PMID:23515621; http://dx.doi.org/10.1007/s00109-013-1021-5
   PubMed Web of Science ®Google Scholar
• Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008; 180:2011-7; PMID:18250403; http://dx.doi.org/10.4049/jimmunol.180.4.2011
   PubMed Web of Science ®Google Scholar
• Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol 2011; 55:861-7; PMID:22161841; http://dx.doi.org/10.1387/ijdb.113371dl
   PubMed Web of Science ®Google Scholar
• Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104:2224-34; PMID:15231578; http://dx.doi.org/10.1182/blood-2004-03-1109
   PubMed Web of Science ®Google Scholar
• Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006; 80:1183-96; PMID:16997855; http://dx.doi.org/10.1189/jlb.0905495
   PubMed Web of Science ®Google Scholar
• Traves SL, Smith SJ, Barnes PJ, Donnelly LE. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol 2004; 76:441-50; PMID:15155777; http://dx.doi.org/10.1189/jlb.1003495
   PubMed Web of Science ®Google Scholar
• Smith DF, Galkina E, Ley K, Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 2005; 289:H1976-84; PMID:15937099; http://dx.doi.org/10.1152/ajpheart.00153.2005
   PubMed Web of Science ®Google Scholar
• Vroon A, Heijnen CJ, Kavelaars A. GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 2006; 80:1214-21; PMID:16943386; http://dx.doi.org/10.1189/jlb.0606373
   PubMed Web of Science ®Google Scholar
• Penela P, Nogues L, Mayor F, Jr. Role of G protein-coupled receptor kinases in cell migration. Curr Opin Cell Biol 2014; 27:10-7; http://dx.doi.org/10.1016/j.ceb.2013.10.005
   PubMed Web of Science ®Google Scholar
• Arraes SM, Freitas MS, da Silva SV, de Paula Neto HA, Alves-Filho JC, Auxiliadora Martins M, Basile-Filho A, Tavares-Murta BM, Barja-Fidalgo C, Cunha FQ. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006; 108:2906-13; PMID:16849637; http://dx.doi.org/10.1182/blood-2006-05-024638
   PubMed Web of Science ®Google Scholar
• Otten JJ, de Jager SC, Kavelaars A, Seijkens T, Bot I, Wijnands E, Beckers L, Westra MM, Bot M, Busch M, et al. Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice. FASEB J 2013; 27:265-76; PMID:23047899; http://dx.doi.org/10.1096/fj.12-205351
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang Y, Li Y, Wang J, Fan L, Scott MJ, Xiao G, Li S, Billiar TR, Wilson MA, et al. TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation. J Immunol 2013; 191:857-64; http://dx.doi.org/10.4049/jimmunol.1300790
   PubMed Web of Science ®Google Scholar
• Ciccarelli M, Sorriento D, Franco A, Fusco A, Del Giudice C, Annunziata R, Cipolletta E, Monti MG, Dorn GW, 2nd, Trimarco B, et al. Endothelial G protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. Arterioscler Thromb Vasc Biol 2013; 33:2415-24; PMID:23950144; http://dx.doi.org/10.1161/ATVBAHA.113.302262
   PubMed Web of Science ®Google Scholar
• De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8:211-26; PMID:16169466; http://dx.doi.org/10.1016/j.ccr.2005.08.002
   PubMed Web of Science ®Google Scholar
• Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez-Sainz MC, Martinez AC, Mayor F, Jr. Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sci U S A 1998; 95:2985-90; PMID:9501202; http://dx.doi.org/10.1073/pnas.95.6.2985
   PubMed Web of Science ®Google Scholar
• Kleibeuker W, Jurado-Pueyo M, Murga C, Eijkelkamp N, Mayor F, Jr., Heijnen CJ, Kavelaars A. Physiological changes in GRK2 regulate CCL2-induced signaling to ERK1/2 and Akt but not to MEK1/2 and calcium. J Neurochem 2008; 104:979-92; PMID:17971124; http://dx.doi.org/10.1111/j.1471-4159.2007.05023.x
   PubMed Web of Science ®Google Scholar
• Patial S, Saini Y, Parvataneni S, Appledorn DM, Dorn GW, 2nd, Lapres JJ, Amalfitano A, Senagore P, Parameswaran N. Myeloid-specific GPCR kinase-2 negatively regulates NF-kappaB1p105-ERK pathway and limits endotoxemic shock in mice. J Cell Physiol 2011; 226:627-37; PMID:20717897; http://dx.doi.org/10.1002/jcp.22384
   PubMed Web of Science ®Google Scholar
• Patial S, Luo J, Porter KJ, Benovic JL, Parameswaran N. G-protein-coupled-receptor kinases mediate TNFalpha-induced NFkappaB signalling via direct interaction with and phosphorylation of IkappaBalpha. Biochem J 2010; 425:169-78; http://dx.doi.org/10.1042/BJ20090908
   Web of Science ®Google Scholar
• Loniewski K, Shi Y, Pestka J, Parameswaran N. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol Immunol 2008; 45:2312-22; PMID:18180038; http://dx.doi.org/10.1016/j.molimm.2007.11.012
   PubMed Web of Science ®Google Scholar
• Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci U S A 2009; 106:4018-23; PMID:19234125; http://dx.doi.org/10.1073/pnas.0900196106
   PubMed Web of Science ®Google Scholar
• Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009; 16:183-94; PMID:19732719; http://dx.doi.org/10.1016/j.ccr.2009.06.017
   PubMed Web of Science ®Google Scholar
• Alves-Filho JC, Sonego F, Souto FO, Freitas A, Verri WA, Jr., Auxiliadora-Martins M, Basile-Filho A, McKenzie AN, Xu D, Cunha FQ, et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010; 16:708-12; PMID:20473304; http://dx.doi.org/10.1038/nm.2156
   PubMed Web of Science ®Google Scholar
• Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, Jurado-Pueyo M, Zalba G, Diez J, Murga C, Fernandez-Veledo S, Mayor F, Jr., Lorenzo M. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 2010; 59:2407-17; PMID:20627936; http://dx.doi.org/10.2337/db10-0771
   PubMed Web of Science ®Google Scholar
• Richard DE, Vouret-Craviari V, Pouyssegur J. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 2001; 20:1556-62; PMID:11313902; http://dx.doi.org/10.1038/sj.onc.1204193
   PubMed Web of Science ®Google Scholar
• Woerner BM, Luo J, Brown KR, Jackson E, Dahiya SM, Mischel P, Benovic JL, Piwnica-Worms D, Rubin JB. Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth. Mol Cancer Res 2012; 10:156-66; PMID:22086906; http://dx.doi.org/10.1158/1541-7786.MCR-11-0411
   PubMed Web of Science ®Google Scholar
• Li W, Ai N, Wang S, Bhattacharya N, Vrbanac V, Collins M, Signoretti S, Hu Y, Boyce FM, Gravdal K, et al. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc Natl Acad Sci U S A 2014; 111:1521-6.
   PubMed Web of Science ®Google Scholar
• Sorriento D, Ciccarelli M, Santulli G, Campanile A, Altobelli GG, Cimini V, Galasso G, Astone D, Piscione F, Pastore L, et al. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci U S A 2008; 105:17818-23; PMID:19008357; http://dx.doi.org/10.1073/pnas.0804446105
   PubMed Web of Science ®Google Scholar
• Sorriento D, Campanile A, Santulli G, Leggiero E, Pastore L, Trimarco B, Iaccarino G. A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. Mol Cancer 2009; 8:97; PMID:19900276; http://dx.doi.org/10.1186/1476-4598-8-97
   PubMed Web of Science ®Google Scholar
• Raghuwanshi SK, Smith N, Rivers EJ, Thomas AJ, Sutton N, Hu Y, Mukhopadhyay S, Chen XL, Leung T, Richardson RM. G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis. J Immunol 2013; 190:5329-36; PMID:23589623; http://dx.doi.org/10.4049/jimmunol.1202058
   PubMed Web of Science ®Google Scholar
• Miyake M, Goodison S, Urquidi V, Gomes Giacoia E, Rosser CJ. Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Invest 2013; 93:768-78; PMID:23732813; http://dx.doi.org/10.1038/labinvest.2013.71
   PubMed Web of Science ®Google Scholar
• Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011; 91:1071-121; PMID:21742796; http://dx.doi.org/10.1152/physrev.00038.2010
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011; 10:417-27; PMID:21629292; http://dx.doi.org/10.1038/nrd3455
   PubMed Web of Science ®Google Scholar
• Kieran MW, Kalluri R, Cho YJ. The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med 2012; 2:a006593; PMID:23209176
   PubMed Web of Science ®Google Scholar
• Cunha SI, Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011; 117:6999-7006; PMID:21467543; http://dx.doi.org/10.1182/blood-2011-01-330142
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Pousa ID, Mate J, Gisbert JP. Angiogenesis in inflammatory bowel disease. Eur J Clin Invest 2008; 38:73-81; PMID:18226040; http://dx.doi.org/10.1111/j.1365-2362.2007.01914.x
   PubMed Web of Science ®Google Scholar